Compound Profiles
GHRP-2
Growth Hormone Releasing Peptide-2 | Pralmorelin
GHRP-2 acts as a synthetic agonist of ghrelin, binding to the growth hormone secretagogue receptor (GHS-R1a) in the hypothalamus and pituitary. This stimulates cAMP production and promotes pulsatile release of endogenous growth hormone without suppressing natural feedback loops.
Ipamorelin
Growth Hormone Secretagogue | Selective GHRP
Binds selectively to ghrelin receptors in pituitary gland, stimulating natural GH release with direct systemic delivery via injection, consistent GH pulse stimulation, no significant cortisol or prolactin elevation, and minimal hunger response..
Combined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take GHRP-2 with Ipamorelin?
Yes, GHRP-2 and Ipamorelin can generally be taken together. Both are GHRPs; can be alternated but typically not stacked together.
Is GHRP-2 and Ipamorelin safe together?
Based on documented research, this combination is considered compatible. However, shared safety flags include: carcinogenic risk, insulin disrupting, teratogenic. Monitor accordingly.
What are the interactions between GHRP-2 and Ipamorelin?
Both are GHRPs; can be alternated but typically not stacked together. This assessment has 90% confidence and is based on documented research data.
How should I time GHRP-2 and Ipamorelin?
GHRP-2 has a half-life of ~30 minutes and Ipamorelin has a half-life of ~2 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.